Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials Group.

Source:http://linkedlifedata.com/resource/pubmed/id/8680885

J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996 Jun 1 12 2 147-52

Download in:

View as

Triples

General Info

PMID
8680885